Tarsus Pharmaceuticals Inc (NASDAQ:TARS) shares are falling Wednesday. Short-seller Culper Research published a report Wednesday alleging the company's sole commercial product relies on an illegal Medicare copay scheme. Here's what you should know.
Tarsus Pharmaceuticals Inc (NASDAQ:TARS) shares are falling Wednesday.
Short-seller Culper Research published a report claiming the company's sole commercial product relies on an alleged illegal Medicare copay scheme.
Here's what you should know.
Tarsus Pharmaceuticals stock is feeling bearish pressure.
What's pressuring TARS stock?
ARS Pharmaceuticals Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of ARS Pharmaceuticals…
ARS Pharmaceuticals stock collapsed Thursday after CVS Caremark declined to add its epinephrine spray to its formulary.
SPRY Investors Have Opportunity to Join ARS Pharmaceuticals, Inc. Fraud Investigation with the Schall Law FirmThe Schall Law…
Wall Street analysts raised concerns about Palantir's elevated valuation and famed hedge fund manager Michael Burry revealed a…
SPRY stock drops after ARS says no new neffy coverage decisions in July formulary cycle.
The semiconductor company beat consensus estimates, but shares plunged as CFO Mike Tate announced that he will be stepping down…
